Progression of luminal breast tumors is promoted by menage a trois between the inflammatory cytokine TNF? and the hormonal and growth-supporting arms of the tumor microenvironment.
Ontology highlight
ABSTRACT: Breast cancer progression is strongly linked to inflammatory processes, aggravating disease course. The impacts of the inflammatory cytokine TNF ? on breast malignancy are not fully substantiated, and they may be affected by cooperativity between TNF ? and other protumoral mediators. Here, we show that together with representatives of other important arms of the tumor microenvironment, estrogen (hormonal) and EGF (growth-supporting), TNF ? potently induced metastasis-related properties and functions in luminal breast tumor cells, representing the most common type of breast cancer. Jointly, TNF? + Estrogen + EGF had a stronger effect on breast cancer cells than each element alone, leading to the following: (1) extensive cell spreading and formation of FAK/paxillin-enriched cellular protrusions; (2) elevated proportion of tumor cells coexpressing high levels of CD44 and ? 1 and VLA6; (3) EMT and cell migration; (4) resistance to chemotherapy; (5) release of protumoral factors (CXCL8, CCL2, MMPs). Importantly, the tumor cells used in this study are known to be nonmetastatic under all conditions; nevertheless, they have acquired high metastasizing abilities in vivo in mice, following a brief stimulation by TNF? + Estrogen + EGF. These dramatic findings indicate that TNF ? can turn into a strong prometastatic factor, suggesting a paradigm shift in which clinically approved inhibitors of TNF? would be applied in breast cancer therapy.
SUBMITTER: Weitzenfeld P
PROVIDER: S-EPMC3867893 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
ACCESS DATA